Indicated for: type 2 diabetes mellitus
Route of administration: oral
Substance: repaglinide (antidiabetic)
ATC: A10BX02 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins)
Repaglinide is a medication used to control blood sugar levels in patients with type 2 diabetes. It stimulates the pancreas to release insulin, thereby helping to lower blood sugar levels after meals.
The medication is taken orally, usually before meals, and should be used as directed by your doctor. It is important to follow the recommended diet and exercise regimen to achieve the best results.
Side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, or weight gain. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of repaglinide.